The Respiratory Disorders Program at Brigham and Women’s Hospital brings together leaders in thoracic surgery, pulmonary medicine and immunology to deliver advanced, multidisciplinary care for patients with a wide array of respiratory diseases, including asthma, chronic obstructive pulmonary disorder (COPD), and cancer (lung, espophageal, and mesothelioma), while working closely with referring physicians to provide complete medical care for their patients.
In 2003, our faculty managed nearly 8,000 pulmonary and critical care outpatient visits and more than 2,500 thoracic surgery cases. Comprising one of the largest practices in the United States, thoracic surgeons at Brigham and Women's hospital have preformed more than 10,000 procedures over the past five years, including more resections for esophageal cancer than any other facility in the Northeast.
Employing a “bench-to-bedside” approach, Brigham and Women’s Hospital researchers have uncovered novel genes and disease pathways that have translated into clinical trials and treatment for patients with respiratory diseases and conditions. In 2003, the Respiratory Disorders Program received more than 24 million dollars in research funding—including 95 grants from the National Institutes of Health
One of the largest practices in the United States, the Thoracic Surgery Division at Brigham and Women’s Hospital has performed more than 10,000 surgical procedures over the past 5 years and managed more resections for esophageal cancer than any other facility in the Northeast.
Brigham and Women’s Hospital performed the first lung transplant in Massachusetts, the first triple organ transplant in the nation, and the first quadruple transplant in New England, harvesting two lungs, a heart, and a kidney from a single donor and giving new hope to four patients awaiting transplants.
Brigham and Women’s Hospital will be the first to conduct clinical trials of a minimally invasive approach to bronchoscopic lung reduction surgery for emphysema treatment.
Researchers at Channing Laboratory, a joint research effort between Brigham and Women’s Hospital and Harvard Medical School, were the first to uncover a gene for steroid treatment response in asthmatics on inhaled steroids.
Send Feedback to: 
